August 20, 2021 Comments Off on New patent for Novartis drug TAFINLAR Posted in: Patent Added Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on DrugPa…
August 20, 2021 Comments Off on New patent for Astrazeneca Ab drug BYDUREON BCISE Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent for Astrazeneca Ab drug BYDUREON BCISE appeared …
